Oncologists debate the proper treatment of a patient with a grade 2 endometrial carcinoma tumor.
Bradley Monk, MD, FACOG, FACS
Advertisement
Articles by Bradley Monk, MD, FACOG, FACS
Physician-researchers discuss the risk of recurrence in endometrial carcinoma and the available treatment options after relapse.
An overview of biomarker testing in endometrial carcinoma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Adagrasib Plus Cetuximab Misses OS, PFS End Points in Pretreated KRAS G12C–Mutated CRC
2
Phase 1 Data Highlight Potential Utility for In Vivo CAR T-Cell Therapy in R/R Myeloma
3
AI Finds New Applications in Oncologic Surgery, Drug and Biomarker Screening, and Clinical Trial Design
4
Epcoritamab Plus Lenalidomide/Rituximab Win EU Approval for R/R Follicular Lymphoma
5